The purpose of this task order is the development and delivery of a quality assurance/quality control (QA/QC) plan and participation in the task order initiation meeting
Ended Awarded Last action
- Contract number
- 75N93021F00002
- Awardee
-
Alchem Laboratories Corporation UEI LD2KY6H7KMQ5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,148
Award facts
- Contract value 100% obligated
- $17,148.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Santa Fe, FL 32615, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$41 | |
| Original award | $17,189 |
About this award
Alchem Laboratories Corporation, doing business as Alchem Laboratories Corp., has been awarded a $17,148.47 delivery order against the Preclinical Services for HIV Therapeutics master indefinite-delivery/indefinite-quantity (IDIQ) contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose of this task order is for Alchem Laboratories to develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services for HIV therapeutics. Work will be performed in Alachua, Florida from April to August 2021. The contract has a cost-plus-fixed-fee pricing structure. This delivery order provides key quality and planning services under the larger Preclinical Services for HIV Therapeutics IDIQ, aimed at advancing the National Institutes of Health's research on treatments for HIV/AIDS.
Quick answers
Who was awarded contract 75N93021F00002?
75N93021F00002 was awarded to Alchem Laboratories Corporation by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2021.
How much is contract 75N93021F00002 worth?
The government has obligated $17,148 on 75N93021F00002.
Is contract 75N93021F00002 an order under another contract?
Yes. 75N93021F00002 is a delivery order under 75N93021D00002, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.
Was contract 75N93021F00002 competed?
The extent of competition for 75N93021F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award